{
    "clinical_study": {
        "@rank": "105940", 
        "acronym": "ORTHODIAB", 
        "arm_group": [
            {
                "arm_group_label": "Group \"Orth\u00e8se Diab\u00e8te\"", 
                "arm_group_type": "Experimental", 
                "description": "Using \"Orth\u00e8se Diab\u00e8te\", a new customized removable device with rocker sole for plantar off-loading"
            }, 
            {
                "arm_group_label": "Control Group", 
                "arm_group_type": "Active Comparator", 
                "description": "Using \"Conventional\" removable off-loading systems among the devices available in France"
            }
        ], 
        "brief_summary": {
            "textblock": "Multi-center trial, randomized in 2 parallel groups, open label, with a blinded adjudication\n      committee (PROBE methodology), comparing \"Orth\u00e8se Diab\u00e8te\" with \"conventional\" removable\n      devices in terms of healing of ulcers.\n\n      - Primary objective: Evaluate the efficiency of \"Orth\u00e8se Diab\u00e8te\" compared to \"conventional\"\n      removable devices, in terms of the proportion of diabetic patients whose principal ulcer\n      will heal completely at 3 months."
        }, 
        "brief_title": "Evaluation of a New Device \"Orth\u00e8se Diab\u00e8te\" in the Healing of Foot Ulcers in Diabetic Patients", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Foot Ulcers in Diabetic Patients", 
        "condition_browse": {
            "mesh_term": [
                "Ulcer", 
                "Foot Ulcer"
            ]
        }, 
        "detailed_description": {
            "textblock": "1. Secondary objectives\n\n             1. Proportion of patients whose principal ulcer will heal completely at 1, 2 and 6\n                months\n\n             2. Proportion of patients in whom all initial plantar ulcers will heal\n                completely at 1, 2, 3 and 6  months\n\n             3. Percentage of area decrease of  the plantar ulcers at 1, 2, 3 and 6  months\n\n             4. Time to healing of the principal ulcer\n\n             5. Appearance of new ulcers\n\n             6. Requirement for amputation\n\n             7. Incidence of the infectious complications\n\n             8. Adherence of wearing\n\n             9. Patient's satisfaction with the prescribed device\n\n        2. Population\n\n             1. 10 centers/110 patients monitored for a period of 6 months maximum\n\n             2. Experimental  Group: \"Orth\u00e8se Diab\u00e8te\" a plantar off-loading custom-made removable\n                device\n\n             3. Control group: \"Conventional\" removable off-loading systems among the devices\n                available in France."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Type 1 or type 2 diabetic patients diagnosed according to the ADA experts consensus\n             [ADA 1997] 33\n\n          -  Over 18 years of age\n\n          -  With a sensory neuropathy (abnormal 10 g monofilament test, i.e. not perceived at\n             least 2 times in 1 of the 3 areas explored : pulp of the great toe, 1st and 5th\n             metatarsal heads)\n\n          -  Without a severe arteriopathy  defined by : ABI < 0,7 and/or TcPO2 < 30 mm Hg and/or\n             big toe pressure < 30 mm Hg\n\n          -  with one or more plantar ulcerations with an area > 0,25 cm\u00b2 or an amputation (toes\n             or transmetatarsal) open or sutured\n\n          -  not requiring a contralateral off-loading device\n\n          -  Informed about the study and having given their informed and written consent to\n             participate\n\n          -  registered with a social security scheme or with the CMU (beneficiary or entitled\n             recipient)\n\n          -  having undergone a medical exam\n\n          -  not included in another protocol throughout the study\n\n        Exclusion Criteria:\n\n          -  Severe skin or osteoarticular infection requiring a parenteral antibiotic therapy or\n             surgery\n\n          -  Large ulcer of the ipsilateral leg > 20 cm2 of area\n\n          -  Contralateral above heel amputation\n\n          -  Intercurrent disease prohibiting participation in the protocol\n\n          -  Weight over 130 Kg\n\n          -  Person  under tutorship or under curatorship\n\n          -  Loss of functional and/or neuropsychological autonomy\n\n          -  Pregnant or likely to be pregnant woman"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01956162", 
            "org_study_id": "PROT-ORTHO-0913"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group \"Orth\u00e8se Diab\u00e8te\"", 
                "intervention_name": "Orth\u00e8se Diab\u00e8te", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Control Group", 
                "intervention_name": "\"Conventional\" Device", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 24, 2014", 
        "link": {
            "url": "http://www.sfdiabete.org/"
        }, 
        "location": {
            "contact": {
                "email": "kamel.mohammedi@bch.aphp.fr", 
                "last_name": "Kamel Mohammedi, Diabetologist", 
                "phone": "+33(0)140257301"
            }, 
            "contact_backup": {
                "email": "chilbert@umanis.com", 
                "last_name": "Caroline Hilbert, Proj Manager", 
                "phone": "+33(0)140897386"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75877"
                }, 
                "name": "Bichat Hospital"
            }, 
            "investigator": {
                "last_name": "Kamel Mohammedi, Diabetologist", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of a New Customized Removable Device With Rocker Sole for Plantar Off-Loading \"Orth\u00e8se Diab\u00e8te\" in the Healing of Foot Ulcers in Diabetic Patients", 
        "overall_contact": {
            "email": "kamel.mohammedi@bch.aphp.fr", 
            "last_name": "Kamel Mohammedi, Diabetologist", 
            "phone": "+33(0)140257301"
        }, 
        "overall_contact_backup": {
            "email": "chilbert@umanis.com", 
            "last_name": "Caroline Hilbert, Project Manager", 
            "phone": "+33(0)140897386"
        }, 
        "overall_official": {
            "affiliation": "Bichat Hospital", 
            "last_name": "Kamel Mohammedi, Diabetologist", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluated by taking photographs, measuring the ulcer area (using Digital Photo Planimetry DPP and the software Tracer.exe). Full healing defined by the adjudication committee based on the analysis of the photographs.", 
            "measure": "Evaluate the efficiency of \"Orth\u00e8se Diab\u00e8te\" compared to \"conventional\" removable devices, in terms of the proportion of diabetic patients whose principal ulcer will heal completely.", 
            "safety_issue": "No", 
            "time_frame": "At 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01956162"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Evaluated by taking photographs, measuring the ulcer area (using Digital Photo Planimetry DPP and the software Tracer.exe). Full healing defined by the adjudication committee based on the analysis of the photographs.", 
                "measure": "Proportion of patients whose principal plantar ulcer will be fully healed", 
                "safety_issue": "No", 
                "time_frame": "At 1, 2 and 6 months"
            }, 
            {
                "description": "Evaluated by taking photographs, measuring the ulcer area (using Digital Photo Planimetry DPP and the software Tracer.exe). Full healing defined by the adjudication committee based on the analysis of the photographs.", 
                "measure": "Proportion of patients whose all initial plantar ulcers will be fully healed.", 
                "safety_issue": "No", 
                "time_frame": "At 1, 2, 3 and 6 months"
            }, 
            {
                "description": "The area is evaluated by the last measurement undertaken during the trial or prior to a serious event (death, amputation, orthopedic or vascular surgery).", 
                "measure": "Percentage decrease of the ulcer area", 
                "safety_issue": "No", 
                "time_frame": "At 1, 2, 3 and 6 months"
            }, 
            {
                "measure": "Time to healing of the principal ulcer", 
                "safety_issue": "No", 
                "time_frame": "From the patient's off-loading device delivery visit to the date of healing validated by the adjudication committee"
            }, 
            {
                "description": "The following elements will be specified: cause, side, location, severity, treatment used", 
                "measure": "Appearance of new ulcers on the affected foot and/or contralateral", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "The following elements will be specified: date, side and level.", 
                "measure": "Requirement for amputation", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "This covers cutaneous infections (abscess and lymphangitis, erysipelas, hypodermitis, necrotizing fasciitis, gas gangrene), bone infections (osteitis, arthritis, osteoarthritis) or systemic infections requiring antibiotic therapy (oral or parenteral) or surgery.", 
                "measure": "Incidence of infectious complications", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Daily wear will be evaluated in the 2 groups through a semi-quantitative questionnaire provided to the patient at every visit. This evaluation will be supplemented with readings of the thermal sensor in the \"Orth\u00e8se Diab\u00e8te \" group", 
                "measure": "Observance of the equipment", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Evaluated with the \"QUEST ESAT\" questionnaire", 
                "measure": "Patients satisfaction with the prescribed device", 
                "safety_issue": "No", 
                "time_frame": "At 3 months"
            }
        ], 
        "source": "Proteor Group", 
        "sponsors": {
            "collaborator": {
                "agency": "Soci\u00e9t\u00e9 Francophone du Diab\u00e8te", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Proteor Group", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}